| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |